Effectiveness of Antidepressant Treatments In TRD
January 10, 2025
A comprehensive network meta-analysis recently published offers new...
Read More
The Role of Inflammation in Mental Health
November 9, 2024
Inflammation triggers chemical reactions in the body that can direc...
Read More
Medication-Induced Weight Change Across Common Antidepressant Treatments
October 9, 2024
While antidepressants rank among the most frequently prescribed dru...
Read More
Inflammatory Biomarkers and Risk of Psychiatric Disorders
October 5, 2024
A recent study investigates whether certain inflammatory markers i...
Read More
Poor Sleep Associated with Poorer Antidepressant Response
September 23, 2024
Poor sleep is common in treatment-resistant late-life depression an...
Read More
Esketamine versus Quetiapine Extended Release in Adults with TRD
August 5, 2024
A recent study compared the adverse effects and overall safety of e...
Read More
TMS Treatment Device Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
April 23, 2024
The FDA has recently granted clearance of a transcranial magnetic s...
Read More
Positive Phase 3 Topline Results Evaluating Lumateperone as Adjunctive Therapy for MDD
April 22, 2024
Encouraging results from a Phase 3 clinical trial evaluating lumate...
Read More
Highlights from 2024 NEI Synapse: The Road Forward: Guidelines for the Detection and Management of Treatment-Resistant Depression
April 19, 2024
Major depressive disorder (MDD) can be difficult to treat and if pa...
Read More
Use of SSRIs With Oral Anticoagulants and Risk of Major Bleeding
April 12, 2024
A recent population-based, nested case-control study assessed wheth...
Read More
FDA Clears First Prescription Digital Therapeutic Authorized for Treatment of MDD
April 1, 2024
The FDA has cleared the first prescription digital therapeutic auth...
Read More
Pharmacological Treatments for Psychotic Depression
March 22, 2024
Current treatment guidelines for psychotic depression recommend a c...
Read More